Technology-enabled activation of skin cancer screening for hematopoietic cell transplantation survivors and their primary care providers (TEACH) | BMC Cancer | Full Text

Technology-enabled activation of skin cancer screening for hematopoietic cell transplantation survivors and their primary care providers (TEACH) | BMC Cancer | Full Text

Technology-enabled activation of skin cancer screening for hematopoietic cell transplantation survivors and their primary care providers (TEACH)

Hematopoietic cell transplantation (HCT) is a curative option for a growing number of patients with hematologic diseases and malignancies. However, HCT-related factors, such as total body irradiation used for ...

Authors:Saro H. Armenian, Lanie Lindenfeld, Aleksi Iukuridze, Meagan Echevarria, Samantha Bebel, Catherine Coleman, Ryotaro Nakamura, Farah Abdullah, Badri Modi, Kevin C. Oeffinger, Karen M. Emmons, Ashfaq A. Marghoob and Alan C. Geller

Citation:BMC Cancer 2020 20:721

Content type:Study protocol

 

Published on: 3 August 2020

• ViewFull Text
 
• ViewPDF